"Discussing Key Elements for Joining a Startup Studio: A Team Deliberates Over 10 Crucial Questions Before Signing with Frugal Scientific." Choosing a startup studio is one of the earliest high-stakes decisions a founder makes. The studio will shape your architecture, your timeline, your cap table, and sometimes your whole company culture. A good one shortens the path from idea to launch. A poor fit can leave you with a half-built product, unclear ownership, and less runway

Implementing ISO 27001 for startups: Frugal Scientific guides businesses through enhancing security, optimizing processes, empowering people, and fostering growth with a focus on responsible innovation. For a startup, implementing an information security management system can initially appear to be a major undertaking. With tight product deadlines, changing partner requirements, evolving processes, and limited resources, the thought of implementing ISO 27001 may seem like ad

"Guide for Non-Technical Founders: Key Criteria to Evaluate and Choose a Technical Co-Builder for Your Startup Success." The Fear Every Non-Technical Founder Has You've validated the problem. You know the customers. You understand the regulatory landscape better than most people in the room. And then someone asks: "So who's building this?" If you're a domain expert without a coding background, this is the moment where founders freeze. How do you evaluate someone's technical c

Sunset brainstorming session at Frugal Scientific headquarters, highlighting the innovative journey from idea to scale against a vibrant cityscape backdrop. The Brutal Reality of Building a Startup Alone in India Bangalore is often called India's Silicon Valley — and for good reason. It has the talent density, the investor networks, and the ecosystem energy. But ask any first-time founder in the city what actually kills startups here, and the pitch-deck answer ("bad market fi

Frugal Scientific's Startup Studio Unveils Medlynx's Quik Pharma: Transforming Concepts into Cutting-Edge Pharmaceutical Solutions. The pharmaceutical distribution landscape is a labyrinth of complexities. From manufacturers to wholesalers, distributors, pharmacies, and ultimately, the patient, every handoff introduces potential for inefficiency, delay, and costly errors. The consequences are dire: wasted supplies, significant financial losses due to returns, and ultimately,